Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Domain Therapeutics brings in €2mm via Series B round

Executive Summary

In what appears to be its Series B round, Domain Therapeutics SA--a French company developing small molecules that target GPCRs--has raised €2mm ($2.45mm) from first-time backers Seventure Partners (contributed €1mm) and SODIV, and returning shareholders Alsace Inter Regio Fonds d'Investissement (AIRFI), IP Growth, Auriga Partners, and the company’s chairman. Domain will use the proceeds to continue the discovery and development of GPCRs using its DTect-All platform.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies